Citation Impact
Citing Papers
Assays of different aspects of haemostasis – what do they measure?
2015 StandoutNobel
Influence of Genetic Polymorphisms on the Effect of High- and Standard-Dose Clopidogrel After Percutaneous Coronary Intervention
2012
Is platelet transfusion efficient to restore platelet reactivity in patients who are responders to aspirin and/or clopidogrel before emergency surgery?
2013
High on-thienopyridine platelet reactivity in elderly coronary patients: the SENIOR-PLATELET study
2011
Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update
2013 Standout
Point-of-care genetic testing for personalisation of antiplatelet treatment (RAPID GENE): a prospective, randomised, proof-of-concept trial
2012
A comprehensive map of molecular drug targets
2016 Standout
Macrophages in immunoregulation and therapeutics
2023 Standout
Clinical, Angiographic, and Genetic Factors Associated With Early Coronary Stent Thrombosis
2011
Clarifying the importance of CYP2C19 and PON1 in the mechanism of clopidogrel bioactivation and in vivo antiplatelet response
2012
Influence of the paraoxonase‐1 Q192R genetic variant on clopidogrel responsiveness and recurrent cardiovascular events: a systematic review and meta‐analysis
2012
Genetic Polymorphisms and the Impact of a Higher Clopidogrel Dose Regimen on Active Metabolite Exposure and Antiplatelet Response in Healthy Subjects
2011
Mitochondrial Metabolism as a Target for Cancer Therapy
2020
Paraoxonase 1 (PON1) Gene Variants Are Not Associated With Clopidogrel Response
2011
Prasugrel 5 mg in the Very Elderly Attenuates Platelet Inhibition But Maintains Noninferiority to Prasugrel 10 mg in Nonelderly Patients
2013 StandoutNobel
CYP2C19*2 and other genetic variants affecting platelet response to clopidogrel in patients undergoing percutaneous coronary intervention
2011
Prodrugs—from Serendipity to Rational Design
2011
Carboxylesterase 1 as a Determinant of Clopidogrel Metabolism and Activation
2012
Value of platelet pharmacogenetics in common clinical practice of patients with ST-segment elevation myocardial infarction
2012
Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450-2C19 (CYP2C19) Genotype and Clopidogrel Therapy
2011
Palladium‐Catalyzed Synthesis of Ammonium Sulfinates from Aryl Halides and a Sulfur Dioxide Surrogate: A Gas‐ and Reductant‐Free Process
2014
ABCB1 C3435T Polymorphism and Response to Clopidogrel Treatment in Coronary Artery Disease (CAD) Patients: A Meta-Analysis
2012
Variability in response to clopidogrel: how important are pharmacogenetics and drug interactions?
2011
The paraoxonase‐1 pathway is not a major bioactivation pathway of clopidogrelin vitro
2012
The gain‐of‐function variant allele CYP2C19*17: a double‐edged sword between thrombosis and bleeding in clopidogrel‐treated patients
2011
We need to talk about the Warburg effect
2020
The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition
2016 Standout
CYP2C19 Genotype, Clopidogrel Metabolism, Platelet Function, and Cardiovascular Events
2011
Predicting Clopidogrel Response Using DNA Samples Linked to an Electronic Health Record
2011
Factors associated with the failure of clopidogrel dose-adjustment according to platelet reactivity monitoring to optimize P2Y12-ADP receptor blockade
2012
Targeting ferroptosis as a vulnerability in cancer
2022 Standout
Effect of Paraoxonase-1 Polymorphism on Clinical Outcomes in Patients Treated With Clopidogrel After an Acute Myocardial Infarction
2011
Effect of the CYP2C19*2 and *3 genotypes, ABCB1 C3435T and PON1 Q192R alleles on the pharmacodynamics and adverse clinical events of clopidogrel in Chinese people after percutaneous coronary intervention
2012
Impact of CYP2C19 variant genotypes on clinical efficacy of antiplatelet treatment with clopidogrel: systematic review and meta-analysis
2011
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
The functional G143E variant of carboxylesterase 1 is associated with increased clopidogrel active metabolite levels and greater clopidogrel response
2012
Shedding New Light on Cancer Metabolism: A Metabolic Tightrope Between Life and Death
2020
No association of paraoxonase-1 Q192R genotypes with platelet response to clopidogrel and risk of stent thrombosis after coronary stenting
2011
High on-treatment platelet reactivity and P2Y12 antagonists in clinical trials
2012
Platelet Function Tests in Clinical Cardiology
2013
Antiplatelet agents for the treatment and prevention of atherothrombosis
2011
Clinical Application of CYP2C19 Pharmacogenetics Toward More Personalized Medicine
2013
Influence of paraoxonase-1 Q192R and cytochrome P450 2C19 polymorphisms on clopidogrel response
2012
Sulfur Containing Scaffolds in Drugs: Synthesis and Application in Medicinal Chemistry
2016 Standout
Recent Fascinating Aspects of the CuAAC Click Reaction
2020 StandoutNobel
Paraoxonase-1 Q192R Polymorphism and Antiplatelet Effects of Clopidogrel in Patients Undergoing Elective Coronary Stent Placement
2011
Cytochromes P450 Catalyze Both Steps of the Major Pathway of Clopidogrel Bioactivation, whereas Paraoxonase Catalyzes the Formation of a Minor Thiol Metabolite Isomer
2011
Impact of Genetic Variants on Post-Clopidogrel Platelet Reactivity in Patients After Elective Percutaneous Coronary Intervention
2011
CYP2C19 But Not PON1 Genetic Variants Influence Clopidogrel Pharmacokinetics, Pharmacodynamics, and Clinical Efficacy in Post–Myocardial Infarction Patients
2011
DAMP-sensing receptors in sterile inflammation and inflammatory diseases
2019 Standout
Bench-Stable 5-Stannyl Triazoles by a Copper(I)-Catalyzed Interrupted Click Reaction: Bridge to Trifluoromethyltriazoles and Trifluoromethylthiotriazoles
2017
The Chemistry of Reactive Oxygen Species (ROS) Revisited: Outlining Their Role in Biological Macromolecules (DNA, Lipids and Proteins) and Induced Pathologies
2021 Standout
Metabolic reprogramming and cancer progression
2020 StandoutScience
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Effect of PON1 Q192R Genetic Polymorphism on Clopidogrel Efficacy and Cardiovascular Events in the Clopidogrel in the Unstable Angina to Prevent Recurrent Events Trial and the Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events
2012
Works of Christopher M. Waldmann being referenced
In vivo imaging of mitochondrial membrane potential in non-small-cell lung cancer
2019 Nature
Paraoxonase-1 is a major determinant of clopidogrel efficacy
2010
Copper-Mediated Oxidative Fluorination of Aryl Stannanes with Fluoride
2016
A Closer Look at the Bromine–Lithium Exchange with tert-Butyllithium in an Aryl Sulfonamide Synthesis
2013